Citations

DOBROWOLSKA, K. et al. Retrospective Analysis of the Effectiveness of Remdesivir in COVID-19 Treatment during Periods Dominated by Delta and Omicron SARS-CoV-2 Variants in Clinical Settings. Journal of Clinical Medicine, [s. l.], v. 12, n. 6, p. 2371, 2023. DOI 10.3390/jcm12062371. Disponível em: https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=owf&AN=162807007&authtype=uid&user=rmabrowserextension&password=Br0wserExtension789! Acesso em: 28 set. 2023.

Dobrowolska K, Zarębska-Michaluk D, Brzdęk M, et al. Retrospective Analysis of the Effectiveness of Remdesivir in COVID-19 Treatment during Periods Dominated by Delta and Omicron SARS-CoV-2 Variants in Clinical Settings. Journal of Clinical Medicine. 2023;12(6):2371. doi:10.3390/jcm12062371

Dobrowolska, K., Zarębska-Michaluk, D., Brzdęk, M., Rzymski, P., Rogalska, M., Moniuszko-Malinowska, A., Kozielewicz, D., Hawro, M., Rorat, M., Sikorska, K., Jaroszewicz, J., Kowalska, J., & Flisiak, R. (2023). Retrospective Analysis of the Effectiveness of Remdesivir in COVID-19 Treatment during Periods Dominated by Delta and Omicron SARS-CoV-2 Variants in Clinical Settings. Journal of Clinical Medicine, 12(6), 2371. https://doi.org/10.3390/jcm12062371

Dobrowolska, Krystyna, Dorota Zarębska-Michaluk, Michał Brzdęk, Piotr Rzymski, Magdalena Rogalska, Anna Moniuszko-Malinowska, Dorota Kozielewicz, et al. 2023. “Retrospective Analysis of the Effectiveness of Remdesivir in COVID-19 Treatment during Periods Dominated by Delta and Omicron SARS-CoV-2 Variants in Clinical Settings.” Journal of Clinical Medicine 12 (6): 2371. doi:10.3390/jcm12062371.

Dobrowolska, K. et al. (2023) ‘Retrospective Analysis of the Effectiveness of Remdesivir in COVID-19 Treatment during Periods Dominated by Delta and Omicron SARS-CoV-2 Variants in Clinical Settings’, Journal of Clinical Medicine, 12(6), p. 2371. doi:10.3390/jcm12062371.

Dobrowolska, K, Zarębska-Michaluk, D, Brzdęk, M, Rzymski, P, Rogalska, M, Moniuszko-Malinowska, A, Kozielewicz, D, Hawro, M, Rorat, M, Sikorska, K, Jaroszewicz, J, Kowalska, J & Flisiak, R 2023, ‘Retrospective Analysis of the Effectiveness of Remdesivir in COVID-19 Treatment during Periods Dominated by Delta and Omicron SARS-CoV-2 Variants in Clinical Settings’, Journal of Clinical Medicine, vol. 12, no. 6, p. 2371, viewed 28 September 2023, .

Dobrowolska, Krystyna, et al. “Retrospective Analysis of the Effectiveness of Remdesivir in COVID-19 Treatment during Periods Dominated by Delta and Omicron SARS-CoV-2 Variants in Clinical Settings.” Journal of Clinical Medicine, vol. 12, no. 6, Mar. 2023, p. 2371. EBSCOhost, https://doi.org/10.3390/jcm12062371.

Dobrowolska, Krystyna, Dorota Zarębska-Michaluk, Michał Brzdęk, Piotr Rzymski, Magdalena Rogalska, Anna Moniuszko-Malinowska, Dorota Kozielewicz, et al. “Retrospective Analysis of the Effectiveness of Remdesivir in COVID-19 Treatment during Periods Dominated by Delta and Omicron SARS-CoV-2 Variants in Clinical Settings.” Journal of Clinical Medicine 12, no. 6 (March 15, 2023): 2371. doi:10.3390/jcm12062371.

Dobrowolska K, Zarębska-Michaluk D, Brzdęk M, Rzymski P, Rogalska M, Moniuszko-Malinowska A, et al. Retrospective Analysis of the Effectiveness of Remdesivir in COVID-19 Treatment during Periods Dominated by Delta and Omicron SARS-CoV-2 Variants in Clinical Settings. Journal of Clinical Medicine [Internet]. 2023 Mar 15 [cited 2023 Sep 28];12(6):2371. Available from: https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=owf&AN=162807007&authtype=uid&user=rmabrowserextension&password=Br0wserExtension789!